Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Addenbrooke's Cognitive Examination-III (ACE-III): Preliminary psychometric properties, normative data, and normative thresholds for functionally independent French older adults.

Created on 18 Nov 2026

Authors

Joana O Pinto, Isabelle Pruvot, Héléna Alfonsi, Agathe Frison, Bruno Peixoto

Published in

Applied neuropsychology. Adult. Pages 1-10. Nov 18, 2026. Epub Nov 18, 2026.

Abstract

The Addenbrooke's Cognitive Examination-III (ACE-III) has demonstrated good psychometric properties across different languages and populations. However, psychometric evidence and normative data for the French version remain limited. Therefore, this study aimed to examine the psychometric properties of the ACE-III in functionally independent French older adults and to establish normative data. A total of 103 community-dwelling, functionally independent older adults living in France completed a semistructured interview, the ACE-III, Fried Frailty Phenotype, Geriatric Depression Scale, and University of California Los Angeles Loneliness Scale. Internal consistency, construct validity, and concurrent criterion validity were examined. Regression-based normative equations, normative trajectories, and individualized normative thresholds were developed using age and education. The ACE-III demonstrated good internal consistency (Cronbach's α = .81) and satisfactory construct and concurrent criterion validity evidenced by strong correlations between the global score and subdomains (r = .67 to .92). Age significantly predicted ACE-III performance. Education was retained in the normative models following a theory-driven approach. Regression-based normative equations, normative trajectories, and individualized normative thresholds were established for the total score and each neurocognitive domain. These findings support the use of ACE-III for neurocognitive screening in French older adults. Longitudinal and process-based studies are warranted to further establish its clinical utility.

PMID:
43049383
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement